FCA's Reach At Stake As DOJ Jumps Into 1st Circ. Fight
Drugmakers are poised to gain valuable cover from False Claims Act liability for failing to report patient harm in a case pending at the First Circuit, but the Obama administration is...To view the full article, register now.
Already a subscriber? Click here to view full article